Haemophilia trials in Norway

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A

  Where

  Many Locations

  Age

  7 years to 12 years

  People

  40 worldwide

  Run by

  Bayer

  See details and how to joinNCT07088458
• Phase 4Taking people
  Treatment of Hemophilia A Patients With FVIII Inhibitors

  Where

  Oslo

  People

  120 worldwide

  Run by

  Emory University

  See details and how to joinNCT04023019 · EU 2024-516741-39-00
• No phaseEnrolling by invitation
  A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  Where

  Oslo

  People

  60 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT03745924
• No phaseTaking people
  The European Paediatric Network for Haemophilia Management ( PedNet Registry)

  Where

  Oslo

  People

  4,000 worldwide

  Run by

  PedNet Haemophilia Research Foundation

  See details and how to joinNCT02979119
• Phase 1Taking people
  This is a first in human study, in patients with severe bleeding disorder (hemophilia A), who has developed inhibitory antibodies against coagulation factor VIII.The aim is to study the safety and efficacy of dendritic cells, originating from the patient itself. The dendritic cells has been loaded with coagulation factor VIII for an improved immunological tolerance. (TOLER8)

  Where

  Oslo

  Age

  18 years to 64 years

  People

  4 worldwide

  Run by

  Cell4Cure AB

  See details and how to join2022-502030-12-01 · EU 2022-502030-12-01